检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Primary results from IMfirst, a phase IIIb open label safety study of atezolizumab (ATZ) plus carboplatin (CB)/cisplatin (CP) plus etoposide (ET) in an interventional real-world (RW) clinical setting of extensive-stage small cell lung cancer (ES-SCLC) in Spain

M. R. Garcia Campelo,M. Domine Gomez,J. De Castro Carpeno,A. L. Moreno Vega,S. Ponce Aix, E. Arriola,E. Carcereny Costa,M. Majem Tarruella, G. Huidobro Vence,E. Esteban Gonzalez,J. Fuentes Pradera,A. L. O. Ortega Granados, M. Guillot Morales,B. Massuti Sureda,L. Vila Martinez,A. Blasco Cordellat, C. A. Fajardo, L. Crama, N. Lerones Laborda,M. Cobo Dols

ANNALS OF ONCOLOGY

引用 1|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要